
Number of infected people is projected to drop below 1 million by 2020, but with substantial HCV disease and death burden.

Number of infected people is projected to drop below 1 million by 2020, but with substantial HCV disease and death burden.

Significant weight loss found to reduce disease burden in psoriatic arthritis patients.

States in the south and southwest regions of the country tend to have more uninsured residents, while northern states typically have more insured residents.

Opdivo shows extended overall survival and fewer adverse events in patients with RCC compared with Afinitor.

Antiretroviral drug interactions now included due to high prevalence of HIV coinfection among patients with hepatitis C virus.

Specific vaccine-induced immune responses correlate with reduced HIV infection.

Express Scripts removes specialty pharmacy Linden Care from its network.

Caregivers should be mindful of COPD patient-reported symptoms that may lead to hospitalization.

Daratumumab is a single agent for multiple myeloma in patients who previously received at least 3 lines of therapy.

Study finds many silver plans have higher out-of-pocket costs for most the commonly prescribed HIV treatments.

Approval sought for Imbruvica combination for patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

Marc O'Connor, chief operating officer of Curant Health, discusses counseling patients on a therapeutic regimen for IBD.

Multiple myeloma comorbidities may contribute to the development of pulmonary hypertension.

ABT-494 is a novel selective Janus Kinase 1 inhibitor acting against enzymes implicated in inflammatory diseases and some types of cancer.

Patients with a family history of Lynch syndrome should be presented the option of risk prediction modeling.

How treatment with Harvoni changed the life of a patient infected with HCV.

Clostridium sporogenes bacteria able to eradicate colon cancer tumor cells.

Top news of the week in cancer drug development.

Statins may influence alterations in the airways of asthmatics during restructuring.

Intestinal microbiome found to influence MS disease emergence and progression.

Beneficiaries increasingly choosing health care plans that include some cost-sharing reduction provisions for co-pays and coinsurance.

Positive mood throughout daily life linked to less pain and fewer RA-related restrictions.

Modified version of Adynovate lasts longer in the blood for less frequent injections.

HIV drug Tenofovir may carry a risk of nephrotoxicity.

Top stories of the week on Specialty Pharmacy Times.

Osimertinib (Tagrisso) is a once daily tablet for patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer.

Hormone treatment may prove to be effective alternative option for patients with invasive lobular carcinoma.

MS cognitive screening tool able to predict actual functional performance.

Treatment with sarilumab improves RA signs, symptoms, and physical function.

Patients simultaneously registering at multiple centers had higher transplant rates, lower death rates waiting for a transplant, and greater income.